United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Novo Nordisk’s Fiasp gains FDA approval for fast-acting insulin, enhancing diabetes management in US Novo Nordisk, a leading Danish pharmaceutical company, has secured a significant regulatory milestone with the US FDA approval… bypharmanewsdailyOctober 2, 2017
